Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypochlorous Acid for Blepharitis (Efficacy Evaluation)
ChiCTR2400091422Phase 4Not yet recruiting
- Sponsor
- Wuhan Aier Hankou Eye Hospital
- Start
- Oct 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hypochlorous acid in blepharitis, sponsored by Wuhan Aier Hankou Eye Hospital. Primary endpoints: eyelid margin congestion, eyelid margin morphology and 4 more. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
hypochlorous acid
03
Conditions
blepharitis
Beyond the preview
Go deeper on ChiCTR2400091422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091422.